STUDIES ON THE BIOLOGICAL FUNCTIONS OF THE COMPLEMENT SYSTEM
STUDIES ON THE BIOLOGICAL FUNCTIONS OF THE COMPLEMENT SYSTEM
批准号:
06454594
负责人:
NAGASAWA Shigeharu
金额:
$4.16万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995
中文摘要
我们研究了作为入侵细胞宿主防御的补体系统的生物学功能。通过本项目获得的重要结果如下:1.通过凋亡的细胞激活自体替代补体途径。补体激活不会发生在同源活细胞上。我们观察到当人脐静脉细胞死亡时,这些细胞激活了人类补体替代途径。这种由凋亡细胞激活的自体补体也在人类T细胞系Jurkat细胞中观察到。这些发现表明,新的蛋白质应该表达在凋亡细胞的表面,以诱导自体补体激活。补体激活导致靶细胞与C3b衍生物iC3b的调理。吞噬细胞作为巨噬细胞表达C3受体,并能吞噬包被C3b的细胞。因此,似乎凋亡细胞激活自体补体可能促进吞噬细胞对凋亡细胞的处理。补体受体对Fc受体功能的影响--FCR与CR3的协同作用我们比较了人中性粒细胞对免疫复合体(IC)和IC3b调理衍生物(IC3b-IC)的吞噬作用。经磷脂酶D抑制剂乙醇处理后,iC3b-IC的吞噬功能增强程度与IC相当。抗FCR111B抗体对IC吞噬功能的抑制作用更强,而抗FcR11抗体仅部分抑制IC3b-LC细胞的吞噬功能。这些结果表明,主要的FCR可能不同于IC和IC3b-IC的吞噬作用。
英文摘要
We investigated the biological functions of the complement system, which acts as a host defense for invading cells.The important results obtained bu this project are as follow ;1.Activation of the autologous alternative complement pathway by apoptotic cells. Complement activation does not occur on homologous live cells. We observed the activation of alternative human complement pathway by human umbilical vein cells, when these cells died of apoptotic process. This autologous complement activation by apoptotic cells was also observed with apoptoticJurkat cells, a human T cell line. these findings suggest that novel proteins should be expressed at the surface of apoptotic cell to induce autologouscomplement activation. Complement activation results in the opsonization oftarget cells with C3b derivative, iC3b. Phagocytes sugh as macrophages express C3 receptor and can phagocytose iC3b-coated cells. So, it appears likelythat activation of the autologous complement by apoptotic cells may promote the processing of apoptotic cell by phagocytes.2. The effect of complement receptor upon the functions of Fc receptors--Synergistic function between FcR and CR3. We compared the phagocytosis of immune complexes (IC) and iC3b-opsonized derivatives (iC3b-IC) by human neutrophils. The phagocytosis of iC3b-IC was greater than that of IC.The enhanced phagocytosis of iC3b-IC was decreased to the same level to that of IC upon treatment of cells with ethanol, aninhibitor for phospholipase D.The IC phagocytosis was inhibited more effectively by anti-FcR lllB,whereas the iC3b-lC phagocytosis was partly inhibited only by anti-FcRll . These results in dicate that the main FcR might differin IC and iC3b-IC phagocytosis.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
M. Ohkuro: "Effect of iC3b binding to immune complexes upon the phagocytic response of human neutrophils" FEBS lett.373. 189-192 (1995)
M. Ohkuro:“iC3b 与免疫复合物结合对人类中性粒细胞吞噬反应的影响”FEBS lett.373。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kobayashi, K., et al: "The role of tyrosine phosphorylation and Ca-accumulation in FcR-mekiated phagocytosis of human neutrophils" J.Biochem. 117. 1156-1161 (1995)
Kobayashi, K. 等人:“酪氨酸磷酸化和 Ca 积累在人中性粒细胞 FcR 介导的吞噬作用中的作用”J.Biochem。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
M.Ohkuro: "Effect of C1q on the processing of immune complexes by human neutrophils" Immunology. 83. 507-511 (1994)
M.Ohkuro:“C1q 对人类中性粒细胞免疫复合物加工的影响”免疫学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Matsui: "Activation of the alternative pathway of complement by apoptotic Jurkat cells" FEBS letters. 351. 419-422 (1994)
H.Matsui:“凋亡 Jurkat 细胞激活补体旁路途径”FEBS 信件。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
P. X. Pu: "Purification and charactenization of PK-120, a novel substrate for plasma kalilkrein, from guinea pig plasma." Biol. Pharm. Bull.18. 837-841 (1995)
P. X. Pu:“PK-120 的纯化和表征,PK-120 是一种来自豚鼠血浆的血浆激肽释放酶的新型底物。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 17 条
Studies on effector molecules of innate immunity responsible for cytotoxicity to tumor cells.
-
批准号:10470478
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$9.34万
-
财政年份:1998
-
负责人:NAGASAWA Shigeharu
-
依托单位:
APOPTOSIS AND COMPLEMENT-STUDIES ON THE MECHANISM OF COMPKEMENT ACTIVATION AND THE BIOLOGICAL SIGNIFICANCE
-
批准号:08457601
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.99万
-
财政年份:1996
-
负责人:NAGASAWA Shigeharu
-
依托单位:
Studies on molecular constitution and effector functions of complement system
-
批准号:04454527
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.1万
-
财政年份:1992
-
负责人:NAGASAWA Shigeharu
-
依托单位:
Biochemical Studies on Human Inter- trypsin Inhibitor
-
批准号:62580106
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$0.26万
-
财政年份:1987
-
负责人:NAGASAWA Shigeharu
-
依托单位:
Artificial Organ and Complement----Basic Studies for Development of New Biomedical Polymer
-
批准号:62870104
-
项目类别:Grant-in-Aid for Developmental Scientific Research
-
资助金额:$3.01万
-
财政年份:1987
-
负责人:NAGASAWA Shigeharu
-
依托单位:
海外基金